Skip to main content

Migraine Prevention News (Page 3)

FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine

May 17, 2018 – The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly...

FDA Approves Topamax for Migraine Prevention in Adolescents

March 28, 2014 – Today, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17. This is the first FDA...

FDA Medwatch Alert: Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches

Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics ISSUE: FDA is advising health care...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Migraine

Related drug support groups

lisinopril, clonazepam, metoprolol, bupropion, amlodipine, amitriptyline, propranolol, Topamax, pregabalin, view more... lamotrigine, Depakote, atenolol, topiramate, baclofen, clonidine, nortriptyline, Botox, Emgality, Aimovig, erenumab, Ajovy, nifedipine, verapamil, Qulipta